Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000190715 | SCV000244156 | uncertain significance | Inborn genetic diseases | 2013-07-01 | criteria provided, single submitter | clinical testing | ​Based on the available evidence, the deleterious nature of this alteration is uncertain. |
Center for Pediatric Genomic Medicine, |
RCV000431077 | SCV000511051 | benign | not provided | 2016-09-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000988036 | SCV000652001 | benign | Atrioventricular septal defect 4 | 2023-12-31 | criteria provided, single submitter | clinical testing | |
Centre for Mendelian Genomics, |
RCV000626818 | SCV000747521 | uncertain significance | Pulmonic stenosis; Tricuspid regurgitation; Pulmonary valve atresia | 2017-01-01 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000988036 | SCV001137587 | benign | Atrioventricular septal defect 4 | 2023-08-22 | criteria provided, single submitter | clinical testing | |
Broad Center for Mendelian Genomics, |
RCV000009601 | SCV001435185 | benign | Tetralogy of Fallot | criteria provided, single submitter | research | The heterozygous p.Asp425Asn variant in GATA4 in 2 individuals with congenital heart defects, including an individual with an unaffected parent and the variant (PMID: 18055909), and has been identified in >1% of South Asian chromosomes and 1 homozygote by ExAC (http://gnomad.broadinstitute.org/). In summary, this variant meets criteria to be classified as benign for autosomal dominant congenital heart defects. | |
Victorian Clinical Genetics Services, |
RCV002470705 | SCV002768602 | likely benign | Congenital heart disease | 2020-06-11 | criteria provided, single submitter | clinical testing | Based on the classification scheme VCGS_Germline_v1.3.2, this variant is classified as likely benign. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with congenital heart disease. (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from aspartic acid to asparagine (exon 7). (I) 0251 - This variant is heterozygous. (I) 0308 - Population frequency for this variant is out of keeping with known incidence of congenital heart disease (gnomAD v2: 491 heterozygotes, 2 homozygotes). (SB) 0309 - An alternative amino acid change at the same position to tyrosine has been observed in gnomAD (v3) (1 heterozygote, 0 homozygote). (I) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0604 - Variant is not located in an established domain, motif, hotspot or informative constraint region. (I) 0705 - No comparable missense variants have previous evidence for pathogenicity. (I) 0808 - Previous reports of pathogenicity for this variant are conflicting. This variant has been classified mostly as benign or VUS in ClinVar. The pathogenic report in ClinVar is based on a publication in 2007 (PMID:18055909). (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign |
OMIM | RCV000009600 | SCV000029818 | pathogenic | Atrial septal defect 2 | 2007-12-01 | no assertion criteria provided | literature only | |
OMIM | RCV000009601 | SCV000029819 | pathogenic | Tetralogy of Fallot | 2007-12-01 | no assertion criteria provided | literature only | |
Genome Diagnostics Laboratory, |
RCV001794439 | SCV002034137 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000431077 | SCV002036476 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004018606 | SCV004746067 | likely benign | GATA4-related disorder | 2023-04-11 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |